CoChat

The role of CB 1 in intestinal permeability and inflammation

Open access
Karwad, Mustafa A., Couch, Daniel G., Theophilidou, Elena, Sarmad, Sarir, Barrett, David A., Larvin, Michael, Wright, Karen L., Lund, Jonathan N., O'Sullivan, Saoirse E. · 2017 · The FASEB Journal
Cited by 60

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

The endocannabinoid system has previously been shown to play a role in the permeability and inflammatory response of the human gut. The goal of our study was to determine the effects of endogenous anandamide (AEA) and 2‐arachidonoyl glycerol (2‐AG) on the permeability and inflammatory response of intestinal epithelium under normal, inflammatory, and hypoxic conditions. Human intestinal mucosa was modeled using Caco‐2 cells. Human tissue was collected from planned colorectal resections. Accumulation of AEA and 2‐AG was achieved by inhibiting their metabolizing enzymes URB597 (a fatty acid amide hydrolase inhibitor) and JZL184 (a monoacylglycerol lipase inhibitor). Inflammation and ischemia were simulated with TNF‐α and IFN‐γ and oxygen deprivation. Permeability changes were measured by transepithelial electrical resistance. The role of the CB 1 receptor was explored using CB 1 ‐knockdown (CB 1 Kd) intestinal epithelial cells. Endocannabinoid levels were measured using liquid chromatography–mass spectrometry. Cytokine secretion was measured using multiplex and ELISA. URB597 and JZL184 caused a concentration‐dependent increase in permeability via CB 1 (P < 0.0001) and decreased cytokine production. Basolateral application of JZL184 decreased permeability via CB 1 (P < 0.0001). URB597 and JZL184 increased the enhanced (worsened) permeability caused by inflammation and hypoxia (P < 0.0001 and P < 0.05). CB 1 Kd cells showed reduced permeability response to inflammation (P < 0.01) but not hypoxia. 2‐AG levels were increased in response to inflammation and hypoxia in Caco‐2 cells. In human mucosal tissue, inflammation increased the secretion of granulocyte macrophage‐colony stimulating factor, IL‐12, −13, and −15, which was prevented with ex vivo treatment with URB597 and JZL184, and was inhibited by a CB 1 antagonist. The results of this study show that endogenous AEA and 2‐AG production and CB 1 activation play a key modulatory roles in normal intestinal mucosa permeability and in inflammatory and hypoxic conditions.—Karwad, M. A., Couch, D. G., Theophilidou, E., Sarmad, S., Barrett, D. A., Larvin, M., Wright, K. L., Lund, J. N., O'Sullivan, S. E. The role of CB 1 in intestinal permeability and inflammation. FASEB J . 31, 3267–3277 (2017). www.fasebj.org

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1096/fj.201601346r

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 60

Metadata

Authors
Karwad, M. A., Couch, D. G., Theophilidou, E., Sarmad, S., Barrett, D. A., Larvin, M., Wright, K. L., Lund, J. N., & O'Sullivan, S. E.
Venue
The FASEB Journal
Publisher
Wiley
Published
2017-08
Volume
31
Issue
8
Pages
3267-3277
ISSN
  • 0892-6638 (ISSN-L)
  • 1530-6860
OpenAlex
W2606278622
Cited by
60
References
3
FWCI
2.94
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.